Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Gastro-intestinal

Modifiable Lifestyle Factors

Diet

Laboratory Testing

Blood

Text Availability

Abstract

3302

Full text

2701

Free full text

1218

Publication Types

Journal Article

3374

Research Support, Non-U.S. Gov't

1391

Randomized Controlled Trial

1380

Review

1201

Clinical Trial

579

Multicenter Study

530

Comparative Study

391

Meta-Analysis

204

Systematic Review

151

Research Support, N.I.H., Extramural

144

Clinical Trial, Phase III

118

Observational Study

109

Controlled Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase II

Research Support, U.S. Gov't, Non-P.H.S.

Letter

Editorial

Case Reports

Comment

Clinical Trial, Phase I

Practice Guideline

Network Meta-Analysis

Clinical Trial, Phase IV

Consensus Development Conference

Evaluation Study

Clinical Trial Protocol

News

Video-Audio Media

Pragmatic Clinical Trial

Research Support, N.I.H., Intramural

Validation Study

Retracted Publication

Equivalence Trial

Guideline

Historical Article

Patient Education Handout

Webcast

Clinical Study

Publication Year

From

Quick links

Individual year

2026

2025

2024

129

2023

2022

117

2021

156

2020

159

2019

160

2018

132

2017

144

2016

123

2015

116

2014

116

2013

2012

106

2011

152

2010

144

2009

153

2008

165

2007

118

2006

133

2005

140

2004

136

2003

157

2002

129

2001

155

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Anticholesteremic Agents""[mesh_terms]

3442 Results

Searching titles within these results

Synthetic Approaches Towards Antihypercholesterolemic Drug Simvastatin.

Tanzeela A Fattah, Aamer Saeed, Syeda A Shehzadi

Current organic synthesis 2020;16(5):652-670

Full Text

Abstract

The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.

Decai Chen, Peijuan Gao, Yushu Wang, Qi Zhang, Junteng Zhou

Postgraduate medicine 2018;130(1):129-136

Full Text

Abstract

High-density lipoprotein-raising strategies: update 2010.

Frank Spillmann, Heinz-Peter Schultheiss, Carsten Tschöpe, Sophie Van Linthout

Current pharmaceutical design 2010;16(13):1517-30

Full Text

Abstract

Cholesterol metabolism in humans: a review of methods and comparison of results.

John S Millar, Marina Cuchel

Current opinion in lipidology 2019;29(1):1-9

Full Text

Abstract

Drug interactions of the statins and consequences for drug selection.

R H Böger

International journal of clinical pharmacology and therapeutics 2002;39(9):369-82

Full Text

Abstract

Treatment of dyslipidemia in diabetes.

A J Garber, F O Karlsson

Endocrinology and metabolism clinics of North America 2002;30(4):999-1010

Full Text

Abstract

Inhibition of cholesterol biosynthesis as a new antithrombotic strategy.

E Tremoli, S Colli, M Camera, C Banfi, L Mussoni

Haematologica 2002;86(11 Suppl 2):35

Full Text

Cholesterol Lowering and Prevention of Stroke.

Robert A Hegele, Daniel G Hackam

Stroke 2019;50(2):537-541

Full Text

Recent developments in the treatment of atherosclerosis.

Pathik S Brahmkshatriya, Mitesh H Jani, Mahesh T Chhabria

Journal of enzyme inhibition and medicinal chemistry 2006;21(1):1-15

Free Full Text

Abstract

Nutraceuticals for the treatment of hypercholesterolemia.

Massimo R Mannarino, Stefano Ministrini, Matteo Pirro

European journal of internal medicine 2015;25(7):592-9

Full Text

Abstract

Beta-lactam cholesterol absorption inhibitors.

Duane A Burnett

Current medicinal chemistry 2005;11(14):1873-87

Full Text

Abstract

Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide.

Maurizio R Averna, Davide Noto, Angelo B Cefalù, Antonina Giammanco

Current medicinal chemistry 2020;27(23):3773-3783

Full Text

Abstract

High-density lipoprotein: why all the fuss?

Bharti Mackness, Mike Mackness

Annals of clinical biochemistry 2009;46(Pt 1):5-7

Full Text

Abstract

PROVE-IT proved it: lower is better--pro.

Lawrence A Leiter

The Canadian journal of cardiology 2007;22 Suppl B(Suppl B):91B-94B

Free Full Text

Abstract

Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction.

P Amarenco

Neurology 2001;57(5 Suppl 2):S35-44

Full Text

Abstract

Results: 1 – 15 / 3442

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Anticholesteremic Agents""[mesh_terms]

Synthetic Approaches Towards Antihypercholesterolemic Drug Simvastatin.

The effect and safety of anacetrapib in the treatment of dyslipidemia: a systematic review and meta-analysis.

High-density lipoprotein-raising strategies: update 2010.

Cholesterol metabolism in humans: a review of methods and comparison of results.

Drug interactions of the statins and consequences for drug selection.

Treatment of dyslipidemia in diabetes.

Inhibition of cholesterol biosynthesis as a new antithrombotic strategy.

Cholesterol Lowering and Prevention of Stroke.

Recent developments in the treatment of atherosclerosis.

Nutraceuticals for the treatment of hypercholesterolemia.

Beta-lactam cholesterol absorption inhibitors.

Therapeutic Options for Homozygous Familial Hypercholesterolemia: The Role of Lomitapide.

High-density lipoprotein: why all the fuss?

PROVE-IT proved it: lower is better--pro.

Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction.

Results for
""Anticholesteremic Agents""[mesh_terms]